enVVeno Medical (NVNO) Long-Term Investments (2022 - 2026)

enVVeno Medical's Long-Term Investments history runs 5 years deep, the most recent figure standing at $24.9 million for Q1 2026.

• On a quarterly basis, Long-Term Investments fell 35.99% year-over-year to $24.9 million in Q1 2026; TTM through Mar 2026 was $24.9 million, a 35.99% decrease from a year earlier, with the FY2025 full-year figure at $25.1 million, down 39.37% from the prior year.
• Long-Term Investments slipped to $24.9 million in Q1 2026 per NVNO's latest filing, from $25.1 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $48.4 million in Q3 2024 and bottomed at $2.4 million in Q3 2022.
• The 5-year median for Long-Term Investments is $34.8 million (2022), against an average of $31.5 million.
• Across the five-year window, Long-Term Investments jumped 157.57% in 2023 and slumped 39.37% in 2025, its largest moves.
• Year by year, Long-Term Investments stood at $34.5 million in 2022, then grew by 24.06% to $42.8 million in 2023, then dropped by 3.27% to $41.4 million in 2024, then plunged by 39.37% to $25.1 million in 2025, then slipped by 0.8% to $24.9 million in 2026.
• Per Business Quant, the three latest NVNO Long-Term Investments figures stand at $24.9 million (Q1 2026), $25.1 million (Q4 2025), and $31.0 million (Q3 2025).